Welcome to our dedicated page for Burcon Nutrascience news (Ticker: BRCNF), a resource for investors and traders seeking the latest updates and insights on Burcon Nutrascience stock.
Burcon NutraScience Corporation (OTCQB: BRCNF; TSX: BU) regularly issues news updates that focus on its progress in plant-based protein innovation and commercialization. As a company that describes itself as a global technology leader in high-performance plant-based proteins for the food and beverage industry, its announcements often highlight developments in product performance, customer adoption, and financing activities.
News items from Burcon frequently cover milestones in commercial production and sales of its branded ingredients, such as Puratein® C canola protein, FavaPro™ fava protein, Peazazz® C pea protein, and Solatein™ sunflower protein. The company reports on first commercial production runs, initial commercial sales, and commercial sales orders for its next generation proteins, as well as the progression of customers from evaluation to purchase orders across its pea, canola, and fava platforms.
Burcon’s releases also include updates on scientific and technical validation of its ingredients. For example, the company has reported on a University of Guelph study in which its pea and sunflower proteins were found to outperform a competitor’s pea protein in a plant-based cheese application, with commentary on melt, stretch, and sensory attributes.
In addition, the company’s news flow features financial and corporate developments, including fiscal results, revenue trends from protein sales and contract manufacturing services, non-brokered private placements of convertible debentures, short-term loan agreements, and insider participation in financings. Governance-related announcements, such as board appointments and shareholder meeting results, are also part of its disclosures.
Investors and industry observers who follow Burcon’s news can track how the company describes its commercialization progress, customer pipeline, manufacturing partnerships, and capital structure as it advances its plant-based protein business.
Burcon NutraScience (OTCQB: BRCNF), a global plant-based protein innovation leader, has appointed two new board members and announced its 2025 AGM results. Philip Dowad, a former KPMG audit partner with 43 years of experience in securities regulation, and Richard Nazur Jr., an agricultural commodity markets expert with over 20 years of experience, have joined the board.
At the AGM, all seven director nominees were successfully elected, with approval rates ranging from 71.72% to 99.45%. Shareholders also approved KPMG LLP as auditors and amended the exercise price of outstanding warrants. Mr. Dowad brings expertise in Canadian and U.S. securities requirements, while Mr. Nazur contributes extensive knowledge in global agricultural commodities trading and markets across five continents.
Burcon NutraScience (OTCQB: BRCNF) has achieved its first commercial sales of Puratein C, a high-purity canola protein isolate with over 90% protein content. The product, derived from non-GMO North American canola seeds, features a complete amino acid profile and a perfect PDCAAS score of 1.
Puratein C offers high solubility, light cream color, and mild flavor, making it suitable for various applications including dairy alternatives, beverages, meat analogues, and baked goods. This milestone represents Burcon's successful expansion into new revenue streams and demonstrates its ability to transform agricultural by-products into high-value, sustainable protein ingredients.
Burcon NutraScience (OTCQB: BRCNF) has announced the successful commercial production of Puratein®C, its high-purity canola protein isolate, at the Galesburg facility. The product, featuring over 90% protein content, is now available for immediate customer delivery.
Puratein®C is produced from non-GMO North American canola seeds and boasts a complete amino acid profile with a PDCAAS score of 1. The product's characteristics include high solubility, light cream color, and mild flavor, making it suitable for various applications including dairy alternatives, beverages, meat analogues, and nutraceuticals.
Burcon NutraScience (OTCQB: BRCNF) announced its upcoming annual general and special meeting scheduled for September 17, 2025. The company is seeking shareholder approval for a significant warrant repricing initiative to amend the exercise price of all outstanding warrants to $3.50 per Common Share.
The warrant amendments affect three tranches: 644,043 May 2023 warrants (current price $5.89), 603,094 March 2024 warrants (current price $4.544), and 297,112 Advisory warrants (current price $4.544). CEO Kip Underwood highlighted the company's commercial progress, noting over 150 active customer projects in final evaluation stages.
Due to insider holdings, the amendments require disinterested shareholder approval with separate voting for each warrant tranche, excluding votes from warrant holders and their affiliates.
Burcon NutraScience (OTCQB: BRCNF), a plant-based protein technology company, reported its fiscal 2026 Q1 results with notable progress in commercialization. The company generated revenue of $342,000, a 44% increase year-over-year, driven by initial protein sales and contract manufacturing services at its Galesburg facility.
Key achievements include securing a $6.8 million multi-year production agreement, first commercial production of Peazazz® C pea protein and FavaPro™ fava protein, and facility integration. However, the company reported a net loss of $3.5 million ($0.27 per share) and had $4.2 million in cash as of June 30, 2025. Burcon maintains its calendar 2025 revenue target of $1-3 million.
Burcon NutraScience (OTCQB: BRCNF) has announced the successful commercial production and launch of FavaPro™, a high-purity fava protein isolate containing over 90% protein content. The product, developed through Burcon's proprietary extraction process, is designed for food, beverage, and nutraceutical applications.
FavaPro™ features a neutral flavor profile and off-white color, making it suitable for various applications including dairy alternatives, nutritional beverages, snacks, and baked goods. The protein is derived from fava beans, which are nitrogen-fixing crops that improve soil health and reduce synthetic fertilizer requirements. The product received significant interest at the recent IFT FIRST tradeshow, highlighting strong market demand.
Burcon NutraScience (OTCQB: BRCNF), a global technology leader in plant-based protein innovation, has announced the appointment of Ms. Alex Varty as Interim Chief Financial Officer, effective August 4, 2025. She succeeds Mr. Robert Peets, who served as CFO since July 2024.
Ms. Varty, who joined Burcon in February 2024, brings significant experience in finance and accounting, including senior roles at KPMG LLP. She is a Chartered Professional Accountant with a Bachelor of Science in Biotechnology/Chartered Professional Accounting from the University of Waterloo. The transition comes as Burcon continues its evolution into a revenue-generating, innovation company.
Burcon NutraScience (OTCQB: BRCNF), a global technology leader in plant-based protein innovation, has scheduled its fiscal 2026 first quarter earnings conference call for August 13, 2025, at 5:00 p.m. Eastern time. The company will release its financial results for the quarter ended June 30, 2025, before the call.
CEO Kip Underwood highlighted that Burcon is transitioning from a technology pioneer to a revenue-generating innovation leader in plant protein. Following IFT FIRST, the company has experienced increased customer engagement and is scaling production at its Galesburg facility to meet growing market demand.
Burcon NutraScience (OTCQB: BRCNF), a leader in plant-based protein innovation, will showcase its new Chipotle Black Bean Protein Hummus at the 2025 IFT FIRST Annual Event & Expo in Chicago from July 13-16, 2025. The hummus features a proprietary triple blend of the company's 90%+ pure proteins: Peazazz®C pea protein, Puratein®C canola protein, and Solatein™ sunflower protein.
Visitors to booth S4066 can sample the hummus during special tasting events on July 14-15 from 11 AM to 1 PM. The company will also showcase its Café Latte Plant Protein Beverage and complete portfolio of plant-based proteins, including hemp and fava bean proteins, all featuring neutral flavor profiles and smooth mouthfeel.
Burcon NutraScience (OTCQB: BRCNF) will showcase its innovative plant protein portfolio at the 2025 IFT FIRST Annual Event & Expo in Chicago from July 13-16. The company will feature a new Café Latte beverage concept containing 10 grams of protein per eight-ounce serving, made with their proprietary blend of Peazazz®C pea protein and Solatein™ sunflower protein.
At booth S4066, Burcon will display its complete range of high-purity plant proteins, including products derived from pea, canola, sunflower, hemp, and fava beans. All proteins feature 90%+ purity, neutral flavor, and excellent functionality for various food and beverage applications.
[]FAQ
What is the current stock price of Burcon Nutrascience (BRCNF)?
What is the market cap of Burcon Nutrascience (BRCNF)?
